BIODESIX, INC. Depreciation
BIODESIX, INC. (BDSX) reported Depreciation of $900.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-05
- BIODESIX, INC. depreciation for the quarter ending 2026-06-30 was $900.00K, a 0.00% change year-over-year.
- BIODESIX, INC. depreciation for the quarter ending 2026-03-31 was $900.00K, a 0.00% change year-over-year.
- BIODESIX, INC. depreciation for the quarter ending 2025-09-30 was $900.00K, a 10.00% decline year-over-year.
- BIODESIX, INC. depreciation for the quarter ending 2025-06-30 was $900.00K, a 0.00% change year-over-year.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month |
|---|---|---|---|
| 2026-06-30 | $900.00K 10-Q · filed 2026-08-05 | $1.80M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-04 | ||
| 2025-09-30 | $900.00K 10-Q · filed 2025-11-03 | $1.80M derived: sum of 2 quarters · filed 2026-08-05 | $2.80M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $900.00K 10-Q · filed 2026-08-05 | $1.80M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $900.00K 10-Q · filed 2026-05-04 | ||
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-03 | $1.90M derived: sum of 2 quarters · filed 2025-11-03 | $2.80M 10-Q · filed 2025-11-03 |
| 2024-06-30 | $900.00K 10-Q · filed 2025-08-07 | $1.80M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-13 | ||
| 2023-09-30 | $300.00K 10-Q · filed 2024-11-01 | $600.00K derived: sum of 2 quarters · filed 2024-11-01 | $900.00K 10-Q · filed 2024-11-01 |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-07 | $600.00K 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-08 | ||
| 2022-09-30 | $400.00K 10-Q · filed 2023-11-07 | $800.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.20M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $400.00K 10-Q · filed 2023-08-07 | $800.00K 10-Q · filed 2023-08-07 | |
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-03 | $500.00K derived: sum of 2 quarters · filed 2022-11-03 | $800.00K 10-Q · filed 2022-11-03 |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-04 | $500.00K 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-11 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-15 | $400.00K derived: sum of 2 quarters · filed 2021-11-15 | $600.00K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-10 | $400.00K 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-11 | ||
| 2019-09-30 | $200.00K 10-Q · filed 2020-12-10 | $600.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |